Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia
Sonja I. Berndt, Nicola J. Camp, Christine F. Skibola, Joseph Vijai, Zhaoming Wang, Jian Gu, Alexandra Nieters, Rachel S. Kelly, Karin E. Smedby, Alain Monnereau, Wendy Cozen, Angela Cox, Sophia Wang, Qing Lan, Lauren R. Teras, Moara Machado, Meredith Yeager, Angela Brooks‐Wilson, Patricia Hartge, Mark P. Purdue, Brenda M. Birmann, Claire M. Vajdic, Pierluigi Cocco, Yawei Zhang, Graham G. Giles, Anne Zeleniuch‐Jacquotte, Charles Lawrence, Rebecca Montalvan, Laurie Burdett, Amy Hutchinson, Yuanqing Ye, Timothy G. Call, Tait D. Shanafelt, Anne J. Novak, Neil E. Kay, Mark Liebow, Julie M. Cunningham, Cristine Allmer, Henrik Hjalgrim, Hans‐Olov Adami, Mads Melbye, Bengt Glimelius, Ellen T. Chang, Martha Glenn, Karen Curtin, Lisa Cannon‐Albright, W. Ryan Diver, Brian K. Link, George J. Weiner, Lucía Conde, Paige M. Bracci, Jacques Riby, Donna K. Arnett, Degui Zhi, Justin M. Leach, Elizabeth A. Holly, Rebecca D. Jackson, Lesley F. Tinker, Yolanda Benavente, Núria Sala, Delphine Casabonne, Nikolaus Becker, Paolo Boffetta, Paul Brennan, Lenka Foretová, Marc Maynadié, James McKay, Anthony Staines, Kari G. Chaffee, Sara J. Achenbach, Celine M. Vachon, Lynn R. Goldin, Sara S. Strom, José F. Leis, J. Brice Weinberg, Neil E. Caporaso, Aaron D. Norman, Anneclaire J. De Roos, Lindsay M. Morton, Richard K. Severson, Elio Ríboli, Paolo Vineis, Rudolph Kaaks, Giovanna Masala, Elisabete Weiderpass, María- Dolores Chirlaque, Roel Vermeulen, Ruth C. Travis, Melissa C. Southey, Roger L. Milne, Demetrius Albanes, Jarmo Virtamo, Stephanie J. Weinstein, Jacqueline Clavel, Tongzhang Zheng, Theodore R. Holford, Danylo Villano, Ann Maria, John J. Spinelli, Randy D. GascoyneNature Communications2016 · DOI
Chronic lymphocytic leukemia (CLL) is a common lymphoid malignancy with strong heritability. To further understand the genetic susceptibility for CLL and identify common loci associated with risk, we conducted a meta-analysis of four genome-wide association studies (GWAS) composed of 3,100 cases and 7,667 controls with follow-up replication in 1,958 cases and 5,530 controls. Here we report three new loci at 3p24.1 (rs9880772, EOMES, P=2.55 × 10⁻¹¹), 6p25.2 (rs73718779, SERPINB6, P=1.97 × 10⁻⁸) and 3q28 (rs9815073, LPP, P=3.62 × 10⁻⁸), as well as a new independent SNP at the known 2q13 locus (rs9308731, BCL2L11, P=1.00 × 10⁻¹¹). We find suggestive evidence (P<5 × 10⁻⁷) for two additional new loci at 4q24 (rs10028805, BANK1, P=7.19 × 10⁻⁸) and 3p22.2 (rs1274963, CSRNP1, P=2.12 × 10⁻⁷). Pathway analyses consistently show a strong role for apoptosis, providing further evidence for the importance of this biological pathway in CLL susceptibility.
Introduction
Chronic Lymphocytic Leukemia (CLL) is the most prevalent leukemia among adults in Western countries and exhibits a significant hereditary component. Despite previous genome-wide association studies (GWAS) identifying several risk loci, these findings only account for approximately one-third of the estimated heritability. This study sought to uncover additional genetic drivers by increasing statistical power through a large-scale meta-analysis and to investigate the functional mechanisms by which these variants influence disease risk.
Methods
The researchers utilized a multi-stage genomic approach:
Discovery Meta-analysis: Data from four GWAS cohorts (NCI, UTAH, GEC, and UCSF) were combined, totaling 3,100 cases and 7,667 controls. Imputation based on the 1000 Genomes Project allowed for the analysis of ~8.5 million common single-nucleotide polymorphisms (SNPs).
Joint Analysis: Promising SNPs were validated in a replication phase involving 1,958 cases and 5,530 controls across six independent studies.
Functional Annotation: Integration of expression quantitative trait loci (eQTL) and methylation QTL data helped determine if risk SNPs affected gene expression or DNA methylation.
Pathway Analysis: Computational tools (GRAIL, Webgestalt, GeneMania) were used to identify biological themes among the identified genes.
Key Results
The meta-analysis identified four new independent SNPs reaching genome-wide significance ($P < 5 \times 10^{-8}$) across three novel regions and one previously known locus:
3p24.1 (EOMES): rs9880772
6p25.2 (SERPINB6): rs73718779
3q28 (LPP): rs9815073
2q13 (BCL2L11): A new independent SNP, rs9308731, was identified at this known locus.
Regional association plots for the identified CLL risk loci at 3p24.1, 6p25.2, 3q28, and 2q13.
Suggestive evidence was also found for loci at 4q24 (BANK1) and 3p22.2 (CSRNP1). Collectively, these markers explain about 16.5% of the familial risk for CLL. A polygenic risk score (PRS) analysis revealed that individuals in the highest quintile of genetic risk had a 1.9-fold increased risk of CLL compared to those in the middle quintile.
Discussion and Biological Insights
A central finding of this study is the prominence of the apoptosis pathway. Genes such as BCL2L11, SERPINB6, and CSRNP1 are critical regulators of programmed cell death. In CLL, the failure of cells to undergo apoptosis is a hallmark of the disease, and these genetic findings provide a direct link between inherited variation and this core biological defect.
Furthermore, the study noted a genetic overlap with autoimmune diseases at the 3p24.1 and 3q28 loci, suggesting shared pathways between immune dysfunction and lymphoid malignancy. Functional analysis specifically linked the SNP at 6p25.2 to reduced expression of SERPINB6 in blood, offering a clear hypothesis for its role in leukemogenesis.
Despite these advances, over 80% of CLL heritability remains unexplained, likely due to rare variants or complex structural changes. Future research involving larger, more diverse populations and direct experimental validation (e.g., CRISPR) will be essential to fully map the genetic landscape of CLL.
Summary updated
Abstract
Chronic lymphocytic leukemia (CLL) is a common lymphoid malignancy with strong heritability. To further understand the genetic susceptibility for CLL and identify common loci associated with risk, we conducted a meta-analysis of four genome-wide association studies (GWAS) composed of 3,100 cases and 7,667 controls with follow-up replication in 1,958 cases and 5,530 controls. Here we report three new loci at 3p24.1 (rs9880772, EOMES, P=2.55 × 10(-11)), 6p25.2 (rs73718779, SERPINB6, P=1.97 × 10(-8)) and 3q28 (rs9815073, LPP, P=3.62 × 10(-8)), as well as a new independent SNP at the known 2q13 locus (rs9308731, BCL2L11, P=1.00 × 10(-11)) in the combined analysis. We find suggestive evidence (P<5 × 10(-7)) for two additional new loci at 4q24 (rs10028805, BANK1, P=7.19 × 10(-8)) and 3p22.2 (rs1274963, CSRNP1, P=2.12 × 10(-7)). Pathway analyses of new and known CLL loci consistently show a strong role for apoptosis, providing further evidence for the importance of this biological pathway in CLL susceptibility.
BibTeX
@inproceedings{berndt2016meta,
author = {Sonja I. Berndt and Nicola J. Camp and Christine F. Skibola and Joseph Vijai and Zhaoming Wang and Jian Gu and Alexandra Nieters and Rachel S. Kelly and Karin E. Smedby and Alain Monnereau and Wendy Cozen and Angela Cox and Sophia Wang and Qing Lan and Lauren R. Teras and Moara Machado and Meredith Yeager and Angela Brooks‐Wilson and Patricia Hartge and Mark P. Purdue and Brenda M. Birmann and Claire M. Vajdic and Pierluigi Cocco and Yawei Zhang and Graham G. Giles and Anne Zeleniuch‐Jacquotte and Charles Lawrence and Rebecca Montalvan and Laurie Burdett and Amy Hutchinson and Yuanqing Ye and Timothy G. Call and Tait D. Shanafelt and Anne J. Novak and Neil E. Kay and Mark Liebow and Julie M. Cunningham and Cristine Allmer and Henrik Hjalgrim and Hans‐Olov Adami and Mads Melbye and Bengt Glimelius and Ellen T. Chang and Martha Glenn and Karen Curtin and Lisa Cannon‐Albright and W. Ryan Diver and Brian K. Link and George J. Weiner and Lucía Conde and Paige M. Bracci and Jacques Riby and Donna K. Arnett and Degui Zhi and Justin M. Leach and Elizabeth A. Holly and Rebecca D. Jackson and Lesley F. Tinker and Yolanda Benavente and Núria Sala and Delphine Casabonne and Nikolaus Becker and Paolo Boffetta and Paul Brennan and Lenka Foretová and Marc Maynadié and James McKay and Anthony Staines and Kari G. Chaffee and Sara J. Achenbach and Celine M. Vachon and Lynn R. Goldin and Sara S. Strom and José F. Leis and J. Brice Weinberg and Neil E. Caporaso and Aaron D. Norman and Anneclaire J. De Roos and Lindsay M. Morton and Richard K. Severson and Elio Ríboli and Paolo Vineis and Rudolph Kaaks and Giovanna Masala and Elisabete Weiderpass and María- Dolores Chirlaque and Roel Vermeulen and Ruth C. Travis and Melissa C. Southey and Roger L. Milne and Demetrius Albanes and Jarmo Virtamo and Stephanie J. Weinstein and Jacqueline Clavel and Tongzhang Zheng and Theodore R. Holford and Danylo Villano and Ann Maria and John J. Spinelli and Randy D. Gascoyne},
title = {{Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia}},
booktitle = {Nature Communications},
year = {2016},
doi = {10.1038/ncomms10933},
}